1. Home
  2. TNC vs MESO Comparison

TNC vs MESO Comparison

Compare TNC & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNC
  • MESO
  • Stock Information
  • Founded
  • TNC 1870
  • MESO 2004
  • Country
  • TNC United States
  • MESO Australia
  • Employees
  • TNC N/A
  • MESO N/A
  • Industry
  • TNC Industrial Machinery/Components
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TNC Industrials
  • MESO Health Care
  • Exchange
  • TNC Nasdaq
  • MESO Nasdaq
  • Market Cap
  • TNC 1.4B
  • MESO 1.4B
  • IPO Year
  • TNC N/A
  • MESO N/A
  • Fundamental
  • Price
  • TNC $72.28
  • MESO $10.97
  • Analyst Decision
  • TNC Strong Buy
  • MESO Buy
  • Analyst Count
  • TNC 2
  • MESO 4
  • Target Price
  • TNC $137.50
  • MESO $18.00
  • AVG Volume (30 Days)
  • TNC 133.3K
  • MESO 156.4K
  • Earning Date
  • TNC 04-30-2025
  • MESO 02-26-2025
  • Dividend Yield
  • TNC 1.62%
  • MESO N/A
  • EPS Growth
  • TNC N/A
  • MESO N/A
  • EPS
  • TNC 3.58
  • MESO N/A
  • Revenue
  • TNC $1,265,700,000.00
  • MESO $5,670,000.00
  • Revenue This Year
  • TNC N/A
  • MESO $152.37
  • Revenue Next Year
  • TNC $4.54
  • MESO $336.12
  • P/E Ratio
  • TNC $20.28
  • MESO N/A
  • Revenue Growth
  • TNC 1.35
  • MESO N/A
  • 52 Week Low
  • TNC $67.32
  • MESO $5.78
  • 52 Week High
  • TNC $110.45
  • MESO $22.00
  • Technical
  • Relative Strength Index (RSI)
  • TNC 47.02
  • MESO 44.34
  • Support Level
  • TNC $70.19
  • MESO $10.77
  • Resistance Level
  • TNC $73.63
  • MESO $11.61
  • Average True Range (ATR)
  • TNC 2.10
  • MESO 0.47
  • MACD
  • TNC 0.56
  • MESO 0.09
  • Stochastic Oscillator
  • TNC 78.61
  • MESO 27.68

About TNC Tennant Company

Tennant Co is a manufacturer of floor cleaning equipment, wood flooring, and wood products. It operates in four geographic business units including North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. The company offers products and solutions consisting of mechanized cleaning equipment, detergent-free, and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings, and business solutions such as financing, rental and leasing programs, and machine-to-machine asset management solutions.

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

Share on Social Networks: